AssetMark Inc
TARO

AssetMark Inc’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

AssetMark Inc’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5
Closed – – 1419
2020
Q2 		$0 Hold
5
– – ﹤0.01% 1469
2020
Q1 		$0 Sell
5
-5
-50% -$370 ﹤0.01% 1570
2019
Q4 		$1K Hold
10
– – ﹤0.01% 1356
2019
Q3 		$1K Buy
10
+3
+43% +$243 ﹤0.01% 1279
2019
Q2 		$1K Buy
7
+1
+17% +$99 ﹤0.01% 1302
2019
Q1 		$1K Hold
6
– – ﹤0.01% 1301
2018
Q4 		$1K Sell
6
-6
-50% -$578 ﹤0.01% 1375
2018
Q3 		$1K Hold
12
– – ﹤0.01% 1377
2018
Q2 		$1K Sell
12
-1
-8% -$110 ﹤0.01% 1375
2018
Q1 		$1K Sell
13
-6
-32% -$608 ﹤0.01% 1373
2017
Q4 		$2K Buy
19
+7
+58% +$769 ﹤0.01% 1508
2017
Q3 		$1K Buy
+12
New +$1.31K ﹤0.01% 1425

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

AssetMark Inc's TARO Position: Q3 2020 in Review

AssetMark Inc sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 5 shares.

AssetMark Inc first reported a position in TARO in Q3 2017 and held it in 12 quarters. The position peaked at $2K in Q4 2017. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

  • AssetMark Inc reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
  • AssetMark Inc sold 5 Taro Pharmaceutical Industries Ltd. shares in Q3 2020.
  • AssetMark Inc first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2017 and held it in 12 quarters.
  • AssetMark Inc's Taro Pharmaceutical Industries Ltd. position peaked at $2K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on AssetMark Inc's 13F filing for Q3 2020, filed 13 Nov 2020.